company background image
GLAXOSMITH

GlaxoSmithKline Consumer Nigeria NGSE:GLAXOSMITH Stock Report

Last Price

₦6.15

Market Cap

₦7.4b

7D

0%

1Y

8.9%

Updated

08 Dec, 2022

Data

Company Financials
GLAXOSMITH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

GLAXOSMITH Stock Overview

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria.

GlaxoSmithKline Consumer Nigeria Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GlaxoSmithKline Consumer Nigeria
Historical stock prices
Current Share Price₦6.15
52 Week High₦8.50
52 Week Low₦5.40
Beta0.30
1 Month Change6.96%
3 Month Change4.24%
1 Year Change8.85%
3 Year Change6.03%
5 Year Change-72.96%
Change since IPO41.31%

Recent News & Updates

Recent updates

Shareholder Returns

GLAXOSMITHNG PharmaceuticalsNG Market
7D0%1.7%1.3%
1Y8.9%20.8%3.2%

Return vs Industry: GLAXOSMITH underperformed the NG Pharmaceuticals industry which returned 20.8% over the past year.

Return vs Market: GLAXOSMITH exceeded the NG Market which returned 3.2% over the past year.

Price Volatility

Is GLAXOSMITH's price volatile compared to industry and market?
GLAXOSMITH volatility
GLAXOSMITH Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement4.4%
Market Average Movement5.3%
10% most volatile stocks in NG Market7.2%
10% least volatile stocks in NG Market3.2%

Stable Share Price: GLAXOSMITH is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: GLAXOSMITH's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197164Olakunle Oyelanahttps://www.gsk.com/ng

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over-the-counter (OTC) medicine, and nutritional healthcare products.

GlaxoSmithKline Consumer Nigeria Plc Fundamentals Summary

How do GlaxoSmithKline Consumer Nigeria's earnings and revenue compare to its market cap?
GLAXOSMITH fundamental statistics
Market Cap₦7.35b
Earnings (TTM)₦1.02b
Revenue (TTM)₦26.42b

7.2x

P/E Ratio

0.3x

P/S Ratio

Is GLAXOSMITH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
GLAXOSMITH income statement (TTM)
Revenue₦26.42b
Cost of Revenue₦19.44b
Gross Profit₦6.98b
Other Expenses₦5.96b
Earnings₦1.02b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.85
Gross Margin26.43%
Net Profit Margin3.86%
Debt/Equity Ratio0.0%

How did GLAXOSMITH perform over the long term?

See historical performance and comparison

Dividends

7.3%

Current Dividend Yield

53%

Payout Ratio